Haemonetics Corporation (HAE) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $87.66 +1.67%
EPS Growth %: +15.6%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +15.6%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Haemonetics Corporation (NYSE: HAE) reported Q3 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $231.8 million versus the consensus estimate of $234.85 million.
For earnings history and earnings-related data on Haemonetics Corporation (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Data I/o Corp (DAIO) Misses Q2 EPS by 7c
- Byline Bancorp (BY) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
